1. Home
  2. KYIV vs ZLAB Comparison

KYIV vs ZLAB Comparison

Compare KYIV & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KYIV

Kyivstar Group Ltd.

N/A

Current Price

$12.88

Market Cap

2.9B

Sector

N/A

ML Signal

N/A

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$26.54

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KYIV
ZLAB
Founded
1994
2013
Country
United Arab Emirates
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
KYIV
ZLAB
Price
$12.88
$26.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$18.87
★ $34.13
AVG Volume (30 Days)
590.4K
★ 1.0M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.46
EPS
★ N/A
N/A
Revenue
N/A
★ $460,156,000.00
Revenue This Year
$16.85
N/A
Revenue Next Year
$7.95
$22.41
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 15.33
52 Week Low
$9.29
$15.96
52 Week High
$16.55
$29.02

Technical Indicators

Market Signals
Indicator
KYIV
ZLAB
Relative Strength Index (RSI) 47.85 61.24
Support Level $11.25 $24.24
Resistance Level $14.14 $26.64
Average True Range (ATR) 0.49 1.31
MACD -0.01 0.47
Stochastic Oscillator 17.29 66.85

Price Performance

Historical Comparison
KYIV
ZLAB

About KYIV Kyivstar Group Ltd.

Kyivstar Group Ltd is a telecommunications and digital holding company that operates Ukraine provider of mobile communication and broadband services. The company offers a wide range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as big data, cloud, and cybersecurity. It operates through two main segments: Telecommunications and Digital. The Telecommunications segment, which generates the majority of revenue, includes service revenue from mobile and fixed connectivity services provided to both individual and corporate customers. The Digital segment comprises revenue from proprietary digital platforms and services.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: